ArticlePulmonary medicine2026
Treatment Adherence and Treatment Effectiveness in Stable Chronic Obstructive Pulmonary Disease Among Outpatients at An Giang Province, Vietnam.
Article in Pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRecently, early prevention, treatment, and stabilization of chronic obstructive pulmonary disease (COPD) have become key priorities to reduce exacerbations and improve respiratory function. This study is aimed at evaluating treatment adherence and effectiveness among outpatients with stable COPD in Vietnam.
methodsA cross-sectional descriptive study was conducted on 400 stable COPD outpatients at Kien Giang General Hospital (June 2024-June 2025). Treatment adherence was assessed using the 8-item Morisky Medication Adherence Scale (MMAS-8). Treatment effectiveness was evaluated using three criteria: the number of exacerbations and hospitalizations in the previous 12 months, the modified Medical Research Council (mMRC) dyspnea scale score, and the COPD Assessment Test (CAT) score at two time points: T
resultsAfter 3 months of outpatient follow-up, the treatment adherence rate was 76.5%. The chosen treatment regimen was significantly associated with medication adherence (p < 0.001). Patients using regimens (ICS/LABA + LABA [p.o.]), (SABA + ICS/LABA), and (SABA + ICS/LABA + LABA [p.o.]) had higher adherence than those using ICS/LABA alone. The overall treatment effectiveness improvement rate was 70.3%, with improvements in exacerbations/hospitalizations in the previous 12 months (23.0%), mMRC score (32.3%), and CAT score (66.0%). Although the treatment efficacy index showed positive trends for exacerbations/hospitalizations (11.0%, p = 0.076), mMRC score (3.1%, p = 0.375), and CAT score (3.5%, p = 0.088), these changes did not reach statistical significance, indicating only early positive trends over the 3 months. Multivariate logistic regression analysis identified treatment adherence and smoking status as the strongest predictors of treatment effectiveness.
conclusionPatients with good adherence had substantially higher treatment effectiveness than those with poor adherence. Conversely, smoking status was negatively associated with treatment effectiveness. Further interventional studies targeting these factors are needed to improve medication adherence and treatment effectiveness in patients with stable COPD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.